← All organizations

Cleveland BioLabs

For profitWebsite ↗

Also known as: Cleveland BioLabs, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 1, 2015

Timeline

2000s

Jun 1, 2003
Cleveland BioLabs— Founded

2020s

Feb 17, 2021
Cytocom— Acquired

Drugs by trial phase (5 distinct, 7 trials)

Phase 2 (3 own, 1 via acquisition)

Phase 1 (1 own, 0 via acquisition)

cisplatin

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Cytocom

Recent trials (7)

NCT02778763CollaboratorPhase 2Dec 1, 2015
NCT02715882CollaboratorPhase 2Nov 1, 2015
NCT01728480CollaboratorPhase 1Jan 1, 2014
NCT01527136CollaboratorPhase 1Jan 1, 2012
NCT00574483Study directorPhase 2Nov 1, 2007
NCT00574483Lead sponsorPhase 2Nov 1, 2007
NCT00417274Lead sponsorPhase 2Dec 1, 2006

Details

Founded: Cleveland, OH, US Jun 1, 2003
Last known activity: Dec 1, 2015

Notes

No news since 2016